Post-approval studies (Phase 4)Study completedNCT01945489
What this trial is testing
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Who this might be right for
Overactive Bladder
Allergan 254
Showing 20 of 179 results